Drug Discovery

AI and Compliance in 2025: Predictions for Life Sciences

December 20 by Joanna Edwards

Life sciences professionals discussing AI compliance solutions with a digital interface in a modern office

Discover Dot Compliance’s insights on the future of AI adoption, regulatory challenges, and what lies ahead in 2025

AI in Pharma and Life Sciences: Balancing Innovation with Integrity

September 24 by Joanna Edwards

Mirit Eldor Managing Director Life Sciences Solutions Elsevier

Explore how optimism and ethical concerns shape AI adoption in the Pharma & Healthcare industries in Elsevier's 2024 market report.

Exploring AI's Untapped Potential in Personalised Medicine

September 18 by Joanna Edwards

A futuristic laboratory where scientists use AI tools to analyse personalised patient data, with visuals of DNA strands and molecular structures on large digital screens.

Discover how AI is transforming personalised medicine and patient-specific treatments and how data integration can revolutionise drug discovery and healthcare.

AI's Role in Unveiling the True Value of Health Data

August 30 by Joanna Edwards

Image of Zhana Kuncheva, Director of bioXcelerate AI who is the author of the guest insights on unlocking the true potential of health data with AI.

Understand the potential of AI to unlock the comprehensive value of health data and transform the healthcare sector.

Breaking New Ground: How AI and Protein Patterns Are Changing Disease Prediction

August 14 by Joanna Edwards

Visual representation of AI and protein pattern analysis in predicting diseases like Alzheimer’s and diabetes

Discover how AI and protein pattern analysis are transforming disease prediction. Latest research from Optima Partners, Biogen, and the University of Edinburgh.

Otsuka and Oxford HIN Collaborate on Digital Therapeutic for Major Depressive Disorder

August 14 by Joanna Edwards

Scientists and healthcare professionals working with digital therapeutic technologies for mental health treatment.

Discover how Otsuka and Oxford HIN are collaborating to evaluate and implement CARE for MDD, a digital therapeutic designed to treat major depressive disorder.

Revolutionising Drug Discovery: The Impact of AI and Patient-on-Chip Technology

August 09 by Joanna Edwards

AI and patient-on-chip technology transforming drug discovery and development

Discover how AI and patient-on-chip technology are revolutionising drug discovery and development.

Revolutionising Drug Discovery: AI Advances with Insilico Medicine's PandaOmics Box

July 26 by Joanna Edwards

An advanced AI-powered hardware system (PandaOmics Box) used in a modern laboratory setting.

Discover how AI is transforming drug discovery and the future of AI in pharmaceutical research.

How AI is Revolutionizing Pharmaceutical Research & Development

July 03 by Joanna Edwards

Researchers in a high-tech laboratory utilizing AI and robotics for drug discovery and development. The image features advanced computer screens, robotic arms, and a holographic display of a human figure surrounded by scientific data and molecular structures.

Discover how Artificial Intelligence (AI) is revolutionizing pharmaceutical research and development in this insightful article featuring Renee Iacona, Vice President of Oncology Biometrics at AstraZe...

Clinical

The AI-Powered Path to Revolutionising Rare Disease Research

February 23 by Joanna Edwards

Digital representation of AI neural networks and data points, illustrating the convergence of technology and human elements in healthcare innovation.

Explore how AI/ML can accelerate rare disease research and clinical trials, by enhancing inclusivity and efficiency, to deliver new drugs and therapeutics to patients. With insights from Dr. Harsha Ra...

AI in Pharma: Navigating New Frontiers in Drug Discovery and Development

February 23 by Joanna Edwards

Researchers analysing data on digital interface, symbolising the impact of AI in pharmaceutical innovation and drug discovery.

Bringing a new drug to market typically takes a decade or more and approximately US$2.5 billion. However, new technology, including AI, can dramatically shorten the drug discovery process and reduce t...

Three ways AI is speeding up drug discovery

July 08 by Leila Hawkins

Pharma IQ look’s at how Bristol Myers Squibb, Janssen and Sanofi are using AI in drug discovery

FIND CONTENT BY TYPE

Pharma IQ COMMUNITY

ADVERTISE WITH US

Reach Pharmaceuticals & Biotechnology professionals through cost-effective marketing opportunities to deliver your message, position yourself as a thought leader, and introduce new products, techniques and strategies to the market.

Advertise Now

JOIN THE Pharma IQ COMMUNITY

Join Pharma & Biotech today and interact with a vibrant network of professionals, keeping up to date with the industry by accessing our wealth of articles, videos, live conferences and more.

Pharma IQ, a division of IQPC

Careers With IQPC| Contact Us | About Us | Cookie Policy